Y Intercept (Hong Kong) LTD Anavex Life Sciences Corp. Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 22,631 shares of AVXL stock, worth $196,889. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,631Holding current value
$196,889% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
170Shares Held
27.6MCall Options Held
518KPut Options Held
681K-
Black Rock Inc. New York, NY6.39MShares$55.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$40.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$26.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$16.3 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA913KShares$7.94 Million0.62% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $678M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...